Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe. US tariffs and...
The importance of Wales to the UK life sciences sector has been highlighted in two sets of recent figures that demonstrate strong performance in key aspects...
After repeatedly assuring the nation throughout the referendum campaign that the UK would under no circumstances leave the single market, Boris Johnson is now desperately trying...
